Walleye Trading’s Haemonetics HAE Stock Holding History

Walleye Trading’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,822	Closed	-$547K	–	4357
2025 Q4	$547K	Buy	+6,822	New	+$458K	﹤0.01%	2772
2025 Q3	–	Sell	-3,573	Closed	-$221K	–	4558
2025 Q2	$267K	Buy	3,573 +2,855	+398%	+$189K	﹤0.01%	3061
2025 Q1	$45.6K	Buy	+718	New	+$48.8K	﹤0.01%	3633
2024 Q4	–	Sell	-3,517	Closed	-$282K	–	4394
2024 Q3	$283K	Sell	3,517 -228	-6%	-$18.4K	﹤0.01%	2874
2024 Q2	$310K	Buy	+3,745	New	+$329K	﹤0.01%	2823
2023 Q2	–	Sell	-1,543	Closed	-$128K	–	4883
2023 Q1	$128K	Buy	+1,543	New	+$125K	﹤0.01%	3745
2022 Q3	–	Sell	-11,084	Closed	-$722K	–	5224
2022 Q2	$722K	Buy	+11,084	New	+$656K	﹤0.01%	2540
2022 Q1	–	Sell	-8,916	Closed	-$473K	–	5533
2021 Q4	$473K	Buy	8,916 +1,833	+26%	+$112K	﹤0.01%	3022
2021 Q3	$500K	Sell	7,083 -619	-8%	-$39.1K	﹤0.01%	2912
2021 Q2	$513K	Buy	+7,702	New	+$545K	﹤0.01%	2888
2017 Q1	–	Sell	-700	Closed	-$28K	–	4858
2016 Q4	$28K	Buy	700 +300	+75%	+$11.3K	﹤0.01%	3940
2016 Q3	$14K	Buy	+400	New	+$13.7K	﹤0.01%	4309
2015 Q3	–	Sell	-300	Closed	-$12K	–	5181
2015 Q2	$12K	Buy	+300	New	+$12.6K	﹤0.01%	4228

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Trading's HAE Position: Q1 2026 in Review

Walleye Trading sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 6,822 shares — an estimated $547K sold.

Walleye Trading first reported a position in HAE in Q2 2015 and held it in 13 quarters. The position peaked at $722K in Q2 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Walleye Trading reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
Walleye Trading sold 6,822 Haemonetics shares in Q1 2026, an estimated $547K.
Walleye Trading first reported a position in Haemonetics in Q2 2015 and held it in 13 quarters.
Walleye Trading's Haemonetics position peaked at $722K in Q2 2022.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.